Ruishenan Medical Receives NMPA Approval for Implantable Deep Brain Stimulation System (CNS)

Source: Securities Times

People's Finance News, August 25th: Recently, the implantable deep brain stimulation system (CNS), independently developed by Rishena Medical, has officially been approved for marketing by the National Medical Products Administration. Deep brain stimulation therapy involves implanting electrodes in specific areas of the brain to regulate abnormal neural electrical activity, thereby alleviating disease symptoms. For patients with Parkinson’s disease, tremors, rigidity, and bradykinesia are often the shackles of life, but the intervention of electrical stimulation technology can help them regain smooth movements. The CNS system integrates multiple innovative technologies, including 8-contact electrodes, directional electrodes, sensing capabilities, automatic position detection, visualized remote control, and wireless charging.